Comparison
Why is Zylox-Tonbridge Medical Technology Co., Ltd. ?
- Poor long term growth as Operating profit has grown by an annual rate 34.05% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -160.57
- Over the past year, while the stock has generated a return of 6.73%, its profits have risen by 304% ; the PEG ratio of the company is 0.1
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Zylox-Tonbridge Medical Technology Co., Ltd. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at 7.68%
Highest at 1.53 times
Highest at HKD 630.06 MM
Fallen by -5.01% (YoY
Highest at HKD 1,928.96 MM
Lowest at -51.65 %
Highest at 53.22 times
Highest at HKD 53.22
Highest at HKD 152.13 MM
Highest at 24.15 %
At HKD 128.06 MM has Grown at 97.18%
Highest at HKD 136.41 MM
Highest at HKD 0.42
Here's what is working for Zylox-Tonbridge Medical Technology Co., Ltd.
Net Sales (HKD MM)
Net Profit (HKD MM)
Inventory Turnover Ratio
Net Sales (HKD MM)
Operating Profit (HKD MM)
Operating Profit to Sales
Pre-Tax Profit (HKD MM)
Net Profit (HKD MM)
EPS (HKD)
Cash and Cash Equivalents
Debt-Equity Ratio
Debtors Turnover Ratio
DPS (HKD)
Raw Material Cost as a percentage of Sales






